Novonesis (Novozymes) B (MEX:NSISN) Cyclically Adjusted Book per Share: MXN165.76 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:NSISN Novonesis (Novozymes) B MEX:NSISN
95 GF Score
Price MXN911.11
GF Value MXN936.38
! 5 Warning Signs
View Full Analysis

What is Novonesis (Novozymes) B Cyclically Adjusted Book per Share?

Novonesis (Novozymes) B MEX:NSISN 95 Cyclically Adjusted Book per Share is MXN165.76 as of Jun. 2026. GuruFocus rates MEX:NSISN with a GF Score™ of 95/100 and a GF Value™ of MXN936.38. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Novonesis (Novozymes) B's adjusted book value per share for the three months ended in Jun. 2026 was MXN480.951. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN165.76 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Novonesis (Novozymes) B's average Cyclically Adjusted Book Growth Rate was 25.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 15.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Novonesis (Novozymes) B was 15.00% per year. The lowest was 4.60% per year. And the median was 7.15% per year.

As of today (2026-09-17), Novonesis (Novozymes) B's current stock price is MXN911.11. Novonesis (Novozymes) B's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was MXN165.76. Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio of today is 5.50.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Novonesis (Novozymes) B was 13.63. The lowest was 5.18. And the median was 9.17.


Novonesis (Novozymes) B  (MEX:NSISN) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=911.11/165.76
=5.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Novonesis (Novozymes) B was 13.63. The lowest was 5.18. And the median was 9.17.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Novonesis (Novozymes) B Cyclically Adjusted Book per Share Related Terms


Novonesis (Novozymes) B Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Novonesis (Novozymes) B's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novonesis (Novozymes) B Cyclically Adjusted Book per Share Chart

Novonesis (Novozymes) B Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 121.11 147.23 110.45 117.03 149.89

Novonesis (Novozymes) B Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 120.63 149.72 149.89 168.74 165.76

MEX:NSISN vs LIN, SHW, ECL: Cyclically Adjusted Book per Share Comparison

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis (Novozymes) B Cyclically Adjusted PB Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio falls into.


MEX:NSISN
95GF Score
Novonesis (Novozymes) B MEX:NSISN
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novonesis (Novozymes) B Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novonesis (Novozymes) B's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=480.951/122.9500*122.9500
=480.951

Current CPI (Jun. 2026) = 122.9500.

Novonesis (Novozymes) B Quarterly Data

Book Value per Share CPI Adj_Book
201609 106.870 100.200 131.134
201612 115.344 100.300 141.391
201703 99.728 101.200 121.162
201706 98.655 101.200 119.858
201709 106.513 101.800 128.642
201712 119.935 101.300 145.568
201803 105.062 101.700 127.014
201806 113.539 102.300 136.458
201809 110.757 102.400 132.984
201812 118.839 102.100 143.107
201903 111.298 102.900 132.984
201906 112.208 102.900 134.072
201909 115.056 102.900 137.475
201912 114.325 102.900 136.601
202003 132.410 103.300 157.597
202006 134.405 103.200 160.127
202009 135.210 103.500 160.619
202012 130.779 103.400 155.506
202103 126.346 104.300 148.938
202106 126.730 105.000 148.395
202109 135.887 105.800 157.914
202112 133.022 106.600 153.425
202203 120.258 109.900 134.538
202206 125.162 113.600 135.464
202209 132.330 116.400 139.776
202212 138.661 115.900 147.096
202303 120.628 117.300 126.438
202306 120.529 116.400 127.311
202309 130.035 117.400 136.182
202312 125.194 116.700 131.899
202403 0.000 118.400 0.000
202406 467.296 118.500 484.844
202409 0.000 118.900 0.000
202412 523.595 118.900 541.430
202503 532.803 120.200 544.993
202506 501.102 120.700 510.443
202509 496.748 121.600 502.263
202512 491.229 121.180 498.404
202603 488.261 121.670 493.398
202606 480.951 122.950 480.951

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of MXN165.76 mean?
Novonesis (Novozymes) B (MEX:NSISN) has a Cyclically Adjusted Book per Share of MXN165.76 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Novonesis (Novozymes) B and its competitors.
Is Novonesis (Novozymes) B's Cyclically Adjusted Book per Share too high?
Novonesis (Novozymes) B's current Cyclically Adjusted Book per Share is MXN165.76. Overall, Novonesis (Novozymes) B has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Novonesis (Novozymes) B's Cyclically Adjusted Book per Share compare to LIN and SHW?
Novonesis (Novozymes) B's Cyclically Adjusted Book per Share of MXN165.76 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Chemicals company?
A good Cyclically Adjusted Book per Share depends on the Chemicals industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Novonesis (Novozymes) B and its competitors. Novonesis (Novozymes) B's current Cyclically Adjusted Book per Share is MXN165.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novonesis (Novozymes) B stock overvalued right now?
Novonesis (Novozymes) B (MEX:NSISN) has a current Cyclically Adjusted Book per Share of MXN165.76. The stock's GF Value™ is MXN936.38, compared to a current price of MXN911.11 — trading 2.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is MXN165.76. Novonesis (Novozymes) B's overall GF Score™ is 95/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Novonesis (Novozymes) B (MEX:NSISN), the current Cyclically Adjusted Book per Share is MXN165.76 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novonesis (Novozymes) B (MEX:NSISN) Overvalued in 2026?

Based on GuruFocus' analysis, Novonesis (Novozymes) B stock appears to be undervalued. The current stock price of MXN911.11 is trading 2.7% below its estimated GF Value™ of MXN936.38.

Key valuation signals for MEX:NSISN:

  • Cyclically Adjusted Book per Share: MXN165.76
  • GF Value™: MXN936.38 vs. price of MXN911.11 (2.7% below fair value)
  • GF Score™: 95/100 with 5 warning signs

No single metric tells the full story. See the MEX:NSISN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novonesis (Novozymes) B Business Description

Address Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs more than 11,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
95GF Score

Get the complete analysis for MEX:NSISN

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN911.11
Price
MXN936.38
GF Value